An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model

In order to identify more effective therapy for recalcitrant osteosarcoma, we evaluated the efficacy of an mTOR-VEGFR inhibitor combination on tumor growth in a unique osteosarcoma patient-derived orthotopic xenograft (PDOX) mouse model derived from the lung metastasis of an osteosarcoma patient who...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshiro, Hiromichi, Tome, Yasunori, Miyake, Kentaro, Higuchi, Takashi, Sugisawa, Norihiko, Kanaya, Fuminori, Nishida, Kotaro, Hoffman, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060249/
https://www.ncbi.nlm.nih.gov/pubmed/33883561
http://dx.doi.org/10.1038/s41598-021-87553-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060249/
https://www.ncbi.nlm.nih.gov/pubmed/33883561
http://dx.doi.org/10.1038/s41598-021-87553-9

Ejemplares similares